Natco Pharma Ltd buy melinda
Start price
05.04.18
/
50%
?10.04
Target price
04.11.19
€13.39
Performance (%)
0.00%
End price
04.11.19
-
Summary
This prediction ended on 04.11.19 with a price of -. The BUY prediction by melinda closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Natco Pharma Ltd | - | - | - | - |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
Comments by melinda for this prediction
In the thread Natco Pharma Ltd diskutieren
SektorPharmazeutika
05 April 2018 09:42 IST
Natco Pharma steigt bei der Markteinführung der ersten generischen Version von Teriflunomid um 3%
Teriflunomid wird von Sanofi-Genzyme unter der Marke AUBAGIO auf dem amerikanischen Markt vertrieben.
Es gibt keinen Handelsplatz